Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nurite D is a multi-ingredient nutritional supplement developed by Health N U Therapeutics. It contains a combination of methylcobalamin, alpha lipoic acid, vitamin D3, pyridoxine hydrochloride, and folic acid. This formulation is primarily indicated for the management of diabetic neuropathy, peripheral neuropathy, and nutritional deficiencies. Methylcobalamin and pyridoxine support nerve health and regeneration, while alpha lipoic acid acts as a potent antioxidant to reduce oxidative stress in nerve tissues. Vitamin D3 and folic acid contribute to overall metabolic and cellular health. Together, these components work synergistically to improve nerve conduction velocity and alleviate symptoms such as numbness, tingling, and burning sensations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha lipoic acid + folic acid + methylcobalamin + pyridoxine + vitamin d3.